Sleep-disordered Breathing After Solid Organ Transplantation
1 other identifier
observational
300
1 country
1
Brief Summary
Sleep-disordered breathing (SDB) describes a group of disorders in which partial or complete cessation of breathing occurs many times throughout the night, resulting in daytime sleepiness or fatigue that interferes with a person's ability to function and reduces quality of life. Transplantation has become an important treatment modality for end-stage organ failure. Transplant recipients are now living longer and, hence, develop chronic adverse medical conditions. Furthermore, transplantation is associated with weight gain. Despite the high prevalence of poor sleep and cardiovascular conditions among transplant patients, SDB is not well studied in these patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
September 27, 2016
CompletedFirst Posted
Study publicly available on registry
May 5, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedJuly 3, 2024
July 1, 2024
11.1 years
September 27, 2016
July 2, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Number of participants with SDB and type (central or obstructive) of SDB
Prevalence of different types of SDB after lung transplantation
1 year after lung transplantation
Secondary Outcomes (4)
Echocardiography
1 year after lung transplantation
Lung function measurement
1 year after lung transplantation
Blood analysis
1 year after lung transplantation
24h blood pressure
1 year after lung transplantation
Study Arms (1)
SDB and lung transplantation
Polysomnography at 1 year after lung transplantation.
Interventions
Eligibility Criteria
Patients 1 year after lung transplantation are systematically evaluated by polysomnography.
You may qualify if:
- Patients 1 year after lung transplantation
You may not qualify if:
- Refusal of PSG
- Medical contra-indication to perform PSG
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UZ Leuven
Leuven, 3000, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dries Testelmans, MD, PhD
UZ Leuven
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 27, 2016
First Posted
May 5, 2017
Study Start
November 1, 2014
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
July 3, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share